Skip to main content
OpenTrials
Completed

NCT Number: NCT02223104

Randomized Controlled Multicenter Study to Evaluate the Performance of Flexima® Active vs. Sensura® in Patients With Colostomy

The purpose of this study is to demonstrate that the performance of Flexima Active is non-inferior to the performance of Sensura.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Bichat Hospital

Paris, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient is at least 18 years old
  • patient having a colostomy with a diameter less than 50 mm for users of midi pouches or having a colostomy with a diameter less than 65 mm for users of maxi pouches
  • patient having a colostomy for at least 1 month
  • patient using currently a one-piece flat ostomy appliance with closed or drainable bags
  • patient using minimum 1 product per day with closed pouches or minimum 1 product every two days with drainable pouches
  • patient capable to apply and remove the pouch himself or with the help of a caregiver (except health care professional)
  • patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
  • patient agrees to test Flexima® Active (size midi or maxi, beige) during 14 days and Sensura® (size midi or maxi, beige) during 14 days
  • patient covered by social security

Exclusion criteria

  • patient receiving or having received, within the last month, chemotherapy or radiotherapy
  • patient currently suffering from peristomal skin complications (bleeding or red and broken skin at the time of inclusion)
  • patient currently receiving or having received within the past three weeks systemic or local steroid medication in the peristomal skin
  • patient already participating in another clinical study or who have previously participated in this investigation
  • pregnant or breast-feeding woman

Treatment and study plan

Flexima Active

Device

SenSura

Device

Primary outcomes

  1. Level of leakage under the skin protector of Flexima Active in comparison with level of leakage under the skin protector of Sensura.

    Time frame: Up to one day for closed pouches and up to two days for drainable pouches.

    The patient will evaluate the level of leakage under the skin protector after each removal of pouch.

    A 4 scale level will be used:

    • "no leakage under the skin protector",
    • "leakage under the skin protector not soiling clothes",
    • "leakage under the skin protector soiling clothes",
    • "sudden and massive leakage under the skin protector".

Secondary outcomes

  1. Assessment of the condition of peristomal skin

    Time frame: At V1 and V2 protocol visits (at day 0 and day 14)

  2. Acceptability of each pouch

    Time frame: At each protocol visit (day 0, day 14 and day 28)

    Acceptability is defined by those criteria:

    Wearing comfort, Flexibility, Conformability (skin protector adaptation to the skin relief), Ease of handling (pouch application and pouch removal), Tack (immediate adhesivity to the skin after application), Adhesivity (during wear time), Residues on the skin after pouch removal, Filter performance (odours neutralization, limitation of ballooning of the bag), Security feeling with skin protector, Overall security feeling, Overall satisfaction with skin protector, Overall satisfaction with the appliance

  3. Preference between Flexima® Active and Sensura®

    Time frame: At each protocol visits (at day 0, day 14 and day 28)

  4. Assessment of the quality of life with Stoma-QoL questionnaire

    Time frame: At each protocol visits (at day 0, day 14 and day 28)

  5. Adverse(s) Event(s)

    Time frame: At each protocol visits (at day 0, day 14 and day 28)

Sponsors and collaborators

Lead sponsor

BBraun Medical SAS

Industry

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 22, 2014
Registry last updated
Jul 31, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.